Nasdaq:US$13.90 (+0.16) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models